No cure available for exposure to potentially deadly ionizing radiation
- UVA researchers have identified compounds that could lead to the first antidote for potentially deadly radiation exposure
- Research was spurred by government concern about terror attacks and nuclear accidents
- For people exposed to sufficient ionizing radiation, doctors can only try to ease their suffering until death
- 2016 is the 30th anniversary of the Chernobyl nuclear accident and the fifth anniversary of the Fukushima nuclear accident
University of Virginia School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a nuclear accident such as Chernobyl.
Some of the compounds, including the drug rapamycin, have previously been shown to extend life in organisms such as worms and flies, though it’s unknown if they would have the same benefit in humans. UVA’s research suggests that these compounds, or similar drugs, might counter the deadly effects of ionizing radiation.
Currently there is no treatment for people exposed to lethal doses of radiation; doctors can only try to ease their suffering until death. “If you’re exposed to a very, very high dose, it’s rapid deterioration and immediate death,” explained John S. Lazo, PhD, of UVA’s Department of Pharmacology. “It’s the lower doses that people – particularly governments – are concerned about. The type of exposure that might result from a dirty bomb or a nuclear accident. How do we alleviate the effects? What’s the antidote? Right now, we just don’t have anything.”
Lazo and his colleague Elizabeth R. Sharlow, PhD, screened a library of more than 3,400 existing drugs, vitamins and other compounds to identify ones that might help cells withstand the effects of radiation exposure. The goal was to keep stem cells – the cells that produce the various cell types in the body – alive long enough to repair the damage caused by radiation.
“We wanted to find already approved drugs that would potentially keep stem cells, or progenitor cells, alive after radiation exposure,” Sharlow said. “That’s very much of interest to the NIH [National Institutes of Health] right now: How can we keep those self-renewing populations alive so they can actually help heal the effects of radiation exposure?”
After they identified potential leads, Sharlow created 3D computer models to compare the substances’ chemical structures. That analysis identified a cluster of promising compounds with similar structures – a tantalizing lead in the quest for an antidote. “If you’re a drug hunter, the way we are, this is really cool information,” Lazo said. “Because you can say, ‘Now I will look in the universe of 40 million compounds. What else looks like that? Are they useful?'”
He noted that it is unlikely any one drug or compound will work on its own. “A lot of us in this field think it will be a cocktail of things you take,” he said. “And if you think you need cocktails, you need the individual ingredients. That’s why we think this is pretty important – because it’s providing new ingredients for that cocktail.”
The Latest on: Radiation antidote
via Google News
The Latest on: Radiation antidote
- Lithium Reverses Radiation Damage After Brain Tumor Treatmenton November 14, 2019 at 11:20 am
"In the past few years, paediatric oncology has become better at saving lives, but does so at a high cost," says Klas Blomgren, consultant and professor of paediatric medicine at the Department of ...
- Lithium can reverse radiation damage after brain tumor treatmenton November 14, 2019 at 4:41 am
consultant and professor of pediatric medicine at the Department of Women's and Children's Health at Karolinska Institutet. "Virtually all children who have received radiation treatment for a ...
- Mercy Regional Medical Center welcomes radiation oncologiston November 12, 2019 at 9:34 pm
Kelly specializes in radiation therapy and brachytherapy. He is fellowship-trained in interstitial and intracavitary brachytherapy. Kelly earned both his undergraduate and Doctor of Medicine degrees ...
- Homoeopathy evolving as an add-on therapy supporting surgery, chemotherapy & radiation in cancer treatmenton November 12, 2019 at 6:32 pm
Homoeopathy is evolving as an add-on therapy that supports surgery, chemotherapy and radiation in treating cancer ... “Same diagnostic methods such as MRI and biopsy are conducted to to diagnose ...
- Medical Radiation Shielding Market 2019-2023| Evolving Opportunities with Amray Medical and ESCO Technologies | Technavioon November 12, 2019 at 11:38 am
The company offers radiation protection lead aprons, personal radiation protection accessories, nuclear medicine solutions, radiotherapy, and radiography. ESCO Technologies is headquartered in the US ...
- The radiation dose management market is projected to reach USD 447 million by 2024 from USD 206 million in 2019, at a CAGR of 16.7%on November 11, 2019 at 7:57 am
Based on modality, the radiation dose management market is segmented into computed tomography (CT), fluoroscopy and interventional imaging, mammography, and nuclear medicine.The fluoroscopy and ...
- Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’on November 7, 2019 at 1:19 pm
The most crucial message for clinicians is that “they are primarily responsible not only for their own personal safety and the patient's safety, but of everyone in the room,” Mark Bates, MD, DSc (West ...
- OSHA’s Ionizing Radiation Page: A Resource Guideon November 7, 2019 at 12:23 am
Nuclear medicine. Radiation oncology. Interventional fluoroscopy or radiology. Cardiac angiography. Nuclear power plants (reactors) and their support facilities. Nuclear weapons production facilities.
- The global nuclear medicine/radiopharmaceuticals market is expected to reach US$ 6,683.99 Mn in 2027 from US$ 3,982.11 Mn in 2018on November 6, 2019 at 4:33 pm
Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific ... are expected to hinder the growth of the market in ...
- Enhancing Cooperation for Effective Nuclear and Radiation Regulatory Systems: IAEA Conference Beginson November 4, 2019 at 7:01 am
This week patient and worker protection in radiation medicine and the interface between safety and security, as well as experiences in decommissioning nuclear installations, are at the core of the ...
via Bing News